RANOZEX

1. All Details: Specifications Active Pharmaceutical Ingredient: Ranolazine. Dosage Form: Film-coated extended-release tablet. Coloring Agents: Sunset Yellow FCF. Storage Environment: Store at room temperature, protected from light and moisture. Regulatory Classification: Schedule H Prescription Drug – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner. Batch Identification: SIG1072A.Date of Manufacture (Mfg. Dt.): 05/2025.Date of Expiration (Exp. Dt.): 04/2027.Maximum Retail Price (M.R.P.): Rs. 139.00 per 10 Tablets (Incl. of all taxes).                                        2. General Information Brand: Ranozex ® Name: Ranolazine Extended Release Tablets Quantity: Strip of 10 Tablets (indicated by “per 10 Tablets”).Type: Prescription Antianginal / Cardiovascular Medication. Factor (Form Factor): Solid oral tablet (Extended release).Maximum Shelf Life: 23 months (From May 2025 to April 2027).Food Preference: Not Applicable. As a core prescription drug, standard consumer dietary food tags (such as vegetarian green dots) are not utilized. FSSAI: Not Applicable. This medicinal product is regulated under the Drugs and Cosmetics Act by the CDSCO, meaning it does not fall under the food jurisdiction or licensing of the FSSAI (Food Safety and Standards Authority of India).                          3. Product Details: Ingredients Each film-coated extended-release tablet contains: Ranolazine: Excipients: q. s. (Quantity Sufficient) 4. Directions: How to Use Dosage: As directed by the Physician. Administration Instructions: The tablet should be swallowed whole. It must not be chewed or crushed, as breaking the physical tablet will destroy the built-in extended-release mechanism and release the medication too quickly into the body.            5. Description Ranozex is a specialized cardiac medication containing of Ranolazine. It operates as an anti-ischemic metabolic modulator, primarily prescribed to treat chronic angina (chest pain related to the heart) by improving myocardial relaxation and blood flow efficiency without significantly altering heart rate or blood pressure. The formulation relies on an extended-release profile to provide a steady therapeutic effect over time. The packaging displays a mandatory red caution strip denoting its status as a controlled, prescription-only therapeutic agent.                                                                                                                                                            6. Manufacturer Information Manufactured in India by: sun pharma laboratories ltd. Plant Address: Plot No. 107-108, Namli Block, P.O. Ranipool, Gangtok, Sikkim-737135.Manufacturing License Number (M.L.): M/645/2014Production Line Reference: 5243886                                                                                                7. Marketed By Marketed by: Sun Pharmaceutical Industries Ltd.